Gargi Patel

Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

Aditya Bardia, Xichun Hu, Rebecca Dent et al. · New England Journal of Medicine · 2024 · 393 citations

Medicine, Oncology, Pharmacotherapy +17

Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies

Gargi Patel, Kunal Jain, Rajiv Kumar et al. · Supportive Care in Cancer · 2013 · 148 citations

Medicine, Oncology, Surgery +3

Trastuzumab deruxtecan (T-DXd) vs physician’s choice of chemotherapy (TPC) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-low or HER2-ultralow metastatic breast cancer (mBC) with prior endocrine therapy (ET): Primary results from DESTINY-Breast06 (DB-06).

Giuseppe Curigliano, Xichun Hu, Rebecca Dent et al. · Journal of Clinical Oncology · 2024 · 102 citations

Medicine, Oncology, Pharmacology +17

Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface

Jeroen Claus, Gargi Patel, Flavia Autore et al. · eLife · 2018 · 74 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD)

Helena A. Yu, Sarah B. Goldberg, Xiuning Le et al. · Clinical Lung Cancer · 2021 · 72 citations · Full text

Medicine, Molecular Medicine, Oncology +14